General Statement of Disclosure:

CONSULTING FEES/HONORARIA: LoDoCo(MODEST) OTHER FINANCIAL BENEFIT: Novo Nordisk Inc.(SIGNIFICANT), Kiniksa Pharmaceuticals (SIGNIFICANT), Horizon Therapeutics (MODEST), Esperion (MODEST)

View Full Disclosure